Valtecne S.p.A. (IT:VLT) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Valtecne S.p.A. has reported a revenue of €24 million for the first nine months of 2024, marking a 0.5% increase from the previous year. The company’s medical business line has grown by 18%, now accounting for nearly 70% of total revenues, reflecting a strategic focus on the burgeoning medical sector.
For further insights into IT:VLT stock, check out TipRanks’ Stock Analysis page.